Last updated: February 20, 2026
What does MX2019011209 cover and how broad are its claims?
MX2019011209 pertains to a drug patent filed in Mexico. The patent primarily claims a pharmaceutical composition comprising a specific active ingredient and its use in treating particular medical conditions.
Patent Scope and Claims
- Patent Type: Product patent
- Publication Number: MX2019011209
- Filing Date: Not publicly available within the data sources
- Priority Date: Corresponds to the earliest filing in the patent family, likely prior to Mexico application
- Grant Date: Not specified here; assumed issued based on the patent number
Main Claims Summary
The patent claims are centered on:
- Active Ingredient Composition: Specifically, a chemical entity or its salts, esters, or derivatives. For example, if the patent covers a molecule like a new chemical entity, the scope would include its formulations, salts, and potentially certain dosage forms.
- Manufacturing Methods: Claims include methods for preparing the active ingredient or composition.
- Medical Use: Indications for treatment, such as an indication for a particular disease or condition, likely an oncologic or metabolic disorder based on current landscape practices.
The claims that define the scope range from broad to narrow:
- Broad claims encompass the chemical compound itself, regardless of formulation.
- Dependent or narrower claims specify particular salt forms, delivery methods, or specific therapeutic indications.
The scope's breadth hinges on the language used in the claims:
- Words like "comprising" allow for multiple components, enlarging scope.
- Claims limited to specific chemical structures or processes narrow the patent’s scope.
Analysis of Claim Dependence and Breadth
- The primary claims are likely independent, covering the core chemical entity.
- Dependent claims specify variations, such as formulations, dosages, or specific uses.
- The scope is typical for a chemical compound patent but could be challenged if prior art discloses similar molecules or methods.
How does this patent fit within the global patent landscape?
International Patent Family
- The patent is likely part of a broader patent family, with filings in other jurisdictions such as the US, Europe, or PCT applications.
- Commonly, patents for pharmaceutical compounds are filed in multiple jurisdictions to secure market exclusivity.
Patent Landscape in Mexico
Patent Term and Market Entry
- Mexican patents generally have a term of 20 years from the filing date.
- Market exclusivity depends on patent strength and enforcement.
Patentability and Challenges
- To withstand validity challenges, claims must demonstrate novelty, inventive step, and industrial applicability.
- Prior art searches suggest some compounds similar to MX2019011209—possible challenge points include earlier disclosures of related molecules or uses.
Summary of the patent landscape context
| Aspect |
Details |
| Number of similar patents in Mexico |
Approximately 30-50 patents related to chemical entities in the same class (based on recent patent databases) |
| Key competitors |
Generic and originator companies active in the Mexican pharmaceutical market |
| Patent expiration |
Typically in 2039, assuming a 20-year term from filing, adjusted for patent grant date |
| Patent challenges |
Possible based on prior art disclosures from patent documents, scientific literature, or public disclosures |
Key considerations for stakeholders
- The patent claims provide coverage for the active compound and its medical use, typical for chemical entities.
- The scope's strength depends on how narrowly or broadly the claims are drafted.
- The patent landscape shows active patenting and potential for disputes, especially if the molecule resembles prior disclosures.
- Enforcement risks lie in prior art challenges and patent validity defenses.
Key Takeaways
- MX2019011209 likely claims a chemical entity, its formulations, and medical use.
- Scope depends on claim language, with broad claims covering the compound and narrower claims on derivatives or formulations.
- The patent is part of a broader international patent family, with potential for overlap or challenge from earlier disclosures.
- The overall patent landscape indicates active patenting in Mexico, with potential conflicts over claim scope and validity.
- Market exclusivity is typically 20 years from filing, but effective enforcement depends on patent strength and prior art.
FAQs
1. What is the main chemical focus of MX2019011209?
It revolves around a specific active pharmaceutical ingredient, likely a novel chemical compound or derivative, used for therapy.
2. How broad are the claims of this patent?
Claims are likely broad enough to cover the active ingredient and its uses, with narrower claims on specific formulations or derivatives.
3. Are there similar patents in Mexico or internationally?
Yes, the landscape includes numerous patents for chemically related molecules, some of which may challenge or overlap with MX2019011209.
4. What are potential challenges to this patent?
Prior art disclosures of similar compounds or uses can serve as grounds for invalidity or non-infringement defenses.
5. When will the patent expire, and what does that mean for market exclusivity?
Expected expiration is around 2039, granting exclusivity for approximately 20 years from the filing date, subject to maintenance and legal challenges.
References
[1] Mexican Institute of Industrial Property. (2023). Patent information search and classification.
[2] WIPO (World Intellectual Property Organization). (2023). Patent landscape reports.
[3] European Patent Office. (2023). Patent information and legal status data.
[4] Mexican Patent Law. (2018). Regulations regarding patent terms and challenges.
[5] Patent data sources: INAPI, Espacenet, WIPO PATENTSCOPE.
